Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Conditions

Osteoporosis 3Prostatic Neoplasms 1Ovarian Neoplasms 1Hypogonadism 1Breast Neoplasms 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Calcium 6Letrozole 4Cholecalciferol 4Calcium Carbonate 4Alendronate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Estradiol 2Denosumab 2Calcium Gluconate 2Aromatase Inhibitors 2Absorptiometry, Photon 2xian ling gu bao 1romosozumab 1X-Rays 1Technetium 1Raloxifene Hydrochloride 1Progesterone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Lysine Acetyltransferase 5 1Ibandronic Acid 1Hormone Replacement Therapy 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Osteoporosis × Alendronate × Clear all
NCT02304757 2021-11-17

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
142 enrolled 7 charts

Osteoporosis

NCT00236002 2009-08-12

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Canadian Urology Research Consortium

Phase 3 Terminated
182 enrolled

Osteoporosis

NCT00391404 2008-05-23

Fosamax for Childhood Cancer Survivors

Chinese University of Hong Kong

Phase 3 Unknown
100 enrolled

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡